Stock Alert: Zogenix Tumbles 15%; Proposes $200 Mln Note Offering

(RTTNews) - Shares of Zogenix Inc. (ZGNX) are falling more than 15 percent or $3.40 in Wednesday's morning trade at $19.18.

Tuesday, Zogenix said it intends to offer $200 million aggregate principal amount of convertible senior notes due 2027 in a private offering to qualified institutional buyers.

The biopharmaceutical company intends to use the net proceeds from the offering to fund development and commercialization of Fintepla in Dravet syndrome, Lennox-Gastaut syndrome, and other potential indications; to fund the development of MT1621 in TK2 deficiency and other general corporate purposes.

Zogenix has traded in a range of $16.65 to $57.22 in the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.